Increased cardiovascular morbidity and mortality in patients with resistance to thyroid hormone

Lancet Diabetes Endocrinol. 2023 Sep;11(9):628-629. doi: 10.1016/S2213-8587(23)00192-4. Epub 2023 Jul 17.

Authors

Samuel Refetoff¹, Luca Persani², W Edward Visser³

Affiliations

¹ Department of Medicine, University of Chicago, Chicago, IL, USA.
² Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy; BIOMETRA, University of Milan, Milan, Italy.
³ Thyroid Centre, Department of Internal Medicine, Erasmus Medical Centre, Rotterdam 3015 GE, Netherlands. Electronic address: w.e.visser@erasmusmc.nl.

PMID: 37475120
DOI: 10.1016/S2213-8587(23)00192-4

No abstract available

Publication types

Comment

MeSH terms

Cardiovascular Diseases* / epidemiology
Disease Progression
Humans
Thyroid Hormones*

Substances

Thyroid Hormones